Epifocal dinitrochlorobenzene therapy in malignant melanoma (experience during the last eight years).
Illig L, Paul E, Bödeker R H·Anticancer research
A total of 50 patients with primary malignant melanomas received epifocal DNCB therapy. In 46 cases the tumors disappeared completely. Therefore, we partly refrained from excision of the treated area. Only 4 melanomas of great thickness did not respond satisfactorily. In the treatment of cutaneous metastases, however,…